Vertex PharmaceuticalsVRTX 
$474.16-1.48%24h
-1.48%24h
Global rank113
Market cap$122.19B
Change 7d-3.23%
YTD Performance17.08%
SP500 benchmarkUnderperform
P/E34.14
P/S12.38
Revenue$9.87B
Earnings$3.62B
Dividend yield-
Main Sector
Healthcare
EPS for Vertex Pharmaceuticals (VRTX)
Vertex Pharmaceuticals has an EPS of $13.89. In 2022, the company made an earnings per share (EPS) of $12.82. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for VRTX
-
Value:-
EPS history for Vertex Pharmaceuticals from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | $13.89 | 8.35% |
| 2022 | $12.82 | 42.29% |
| 2021 | $9.01 | -12.44% |
| 2020 | $10.29 | - |
View the highest EPS stocks
